Synthorx, Inc. Common Stock

THOR

Delisted

THOR was delisted on the 22nd of January, 2020.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	RCM 1 RA Capital Management Boston, Massachusetts	$169M	+$141M	+9,724,598	New
2	O 2 OrbiMed New York	$92.4M	+$77.1M	+5,316,355	New
3	3 Fidelity Investments Boston, Massachusetts	$38.6M	+$32.2M	+2,218,587	New
4	CCM 4 Camber Capital Management Boston, Massachusetts	$32.4M	+$27M	+1,862,116	New
5	5 Goldman Sachs New York	$11.4M	+$9.48M	+654,269	New
6	EAM 6 Eventide Asset Management Boston, Massachusetts	$6.95M	+$5.8M	+400,000	New
7	FCM 7 Farallon Capital Management San Francisco, California	$6.71M	+$5.6M	+386,092	New
8	8 Wellington Management Group Boston, Massachusetts	$1.04M	+$870K	+60,041	New
9	MC 9 Matisse Capital Portland, Oregon	$956K	+$798K	+55,033	New
10	DIM 10 DC Investments Management Mclean, Virginia	$827K	+$690K	+47,582	New
11	MIM 11 Monashee Investment Management Boston, Massachusetts	$435K	+$362K	+25,000	New
12	12 Alyeska Investment Group Chicago, Illinois	$348K	+$290K	+20,000	New
13	13 Vanguard Group Malvern, Pennsylvania	$174K	+$145K	+10,000	New
14	PHK 14 Point72 Hong Kong Hong Kong	$153K	+$128K	+8,819	New
15	CSS 15 Cubist Systematic Strategies Stamford, Connecticut	$34K	+$28.5K	+1,968	New
16	TCM 16 Tradewinds Capital Management Bellingham, Washington	$11K	+$9.28K	+640	New
17	CCA 17 Catalyst Capital Advisors Huntington, New York	$8K	+$6.74K	+465	New
18	TRCT 18 Tower Research Capital (TRC) New York	$3K	+$2.13K	+147	New
19	19 Morgan Stanley New York	$2K	+$1.42K	+98	New
20	S 20 SignatureFD Atlanta, Georgia	–	+$29	+2	New